期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 163, 期 7, 页码 1423-1431出版社
WILEY
DOI: 10.1111/j.1476-5381.2011.01352.x
关键词
diet-induced obesity; metabolic syndrome; endocannabinoids; anandamide; 2-arachidonoylglycerol; peripheral CB1 receptors
资金
- National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism)
In this review, we consider the role of endocannabinoids and cannabinoid-1 (CB1) cannabinoid receptors in metabolic regulation and as mediators of the thrifty phenotype that underlies the metabolic syndrome. We survey the actions of endocannabinoids on food intake and body weight, as well as on the metabolic complications of visceral obesity, including fatty liver, insulin resistance and dyslipidemias. Special emphasis is placed on weighing the relative importance of CB1 receptors located in peripheral tissues versus the central nervous system in mediating the metabolic effects of endocannabinoids. Finally, we review recent observations that indicate that peripherally restricted CB1 receptor antagonists retain efficacy in reducing weight and improving metabolic abnormalities in mouse models of obesity without causing behavioural effects predictive of neuropsychiatric side effects in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据